Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

Delayed Quote. Delayed  - 02/08 03:59:58 pm
35.08 USD   -8.55%
01/27 MEDIDATA SOLUTI : Schedules Fourth Quarter Earnings Conference Call ..
01/26 MEDIDATA SOLUTI : ONO PHARMACEUTICAL Selects Medidata to Power Clini..
01/20 MEDIDATA SOLUTI : Celltrion and Medidata Team Up to Transform Global..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

11/11/2013 | 06:31am US/Eastern

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
gjanowitz@mdsol.com


© Business Wire 2013
React to this article
Latest news on MEDIDATA SOLUTIONS INC
01/27 MEDIDATA SOLUTIONS : Schedules Fourth Quarter Earnings Conference Call for Febru..
01/26 MEDIDATA SOLUTIONS : ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trial..
01/20 MEDIDATA SOLUTIONS : Celltrion and Medidata Team Up to Transform Global Clinical..
01/07 MEDIDATA SOLUTIONS : to Present at J.P. Morgan 34th Annual Healthcare Conference
2015 MEDIDATA SOLUTIONS : Boehringer Ingelheim Selects Medidata Clinical Cloud® to Ac..
2015 MEDIDATA SOLUTIONS : Partners with Leading Korean CRO C&R Research to Optimize S..
2015 MEDIDATA SOLUTIONS : Risk-Based Monitoring Solution Selected by Infinity Pharmac..
2015 MEDIDATA SOLUTIONS : ’s Risk-Based Monitoring Solution Selected by Infinit..
2015 MEDIDATA SOLUTIONS : to Host Financial Analyst Day in New York City on December ..
2015 MEDIDATA SOLUTIONS : Chonbuk National University Hospital Selects Medidata Techn..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials